Insider Trading: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

6.82USD
24 Oct 2014
Price Change (% chg)

$0.17 (+2.56%)
Prev Close
$6.65
Open
$6.61
Day's High
$6.82
Day's Low
$6.59
Volume
199,628
Avg. Vol
997,372
52-wk High
$13.64
52-wk Low
$5.22

Search Stocks
Wan Mark A Options Exercised: 0
Trade Date: Thursday, 6 Dec 2012 Price: 3.31
Title: Director and Beneficial Owner Shares Held: 10,367,041
Type Traded: Indirect Net Change in Shares This Filing: 2,416,918

Institutional Holders

% Shares Owned: 85.77%
# of Holders: 120
Total Shares Held: 37,203,917
3 Mo. Net Change: -112,055
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 6
# Reduced Positions: 7
# Net Buyers: -1

Officers & Directors

Name Age Since Current Position

Adrian Adams

63 2013 Independent Chairman of the Board

Richard King

49 2010 President, Chief Executive Officer, Director

Timothy Morris

53 2014 Chief Financial Officer, Principal Accounting Officer

Pamela Palmer

51 2005 Chief Medical Officer, Director

Badri Dasu

50 2007 Chief Engineering Officer

Lawrence Hamel

62 2006 Chief Development Officer

Richard Afable

60 2013 Director

Mark Edwards

56 2011 Independent Director

Stephen Hoffman

60 2010 Independent Director

Howard Rosen

55 2008 Independent Director

Mark Wan

48 2006 Independent Director
Search Stocks